Aberdeen Group plc Buys 3,359 Shares of Synopsys, Inc. $SNPS

Aberdeen Group plc increased its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 2.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 127,534 shares of the semiconductor company’s stock after acquiring an additional 3,359 shares during the quarter. Aberdeen Group plc owned approximately 0.08% of Synopsys worth $65,420,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also bought and sold shares of the company. HBW Advisory Services LLC grew its position in Synopsys by 494.9% during the 2nd quarter. HBW Advisory Services LLC now owns 3,611 shares of the semiconductor company’s stock worth $1,851,000 after acquiring an additional 3,004 shares during the last quarter. Westbourne Investments Inc. bought a new stake in shares of Synopsys in the 2nd quarter worth approximately $1,505,000. Bourgeon Capital Management LLC purchased a new position in shares of Synopsys during the second quarter valued at approximately $451,000. North Star Asset Management Inc. increased its stake in shares of Synopsys by 3.6% during the first quarter. North Star Asset Management Inc. now owns 60,270 shares of the semiconductor company’s stock valued at $25,847,000 after buying an additional 2,082 shares during the period. Finally, SlateStone Wealth LLC increased its stake in shares of Synopsys by 467.8% during the first quarter. SlateStone Wealth LLC now owns 10,220 shares of the semiconductor company’s stock valued at $4,383,000 after buying an additional 8,420 shares during the period. 85.47% of the stock is currently owned by institutional investors.

Synopsys Trading Down 9.4%

NASDAQ SNPS opened at $438.92 on Friday. The company has a quick ratio of 1.51, a current ratio of 1.62 and a debt-to-equity ratio of 0.52. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $651.73. The firm has a market capitalization of $81.53 billion, a PE ratio of 34.45, a P/E/G ratio of 4.84 and a beta of 1.10. The stock’s 50 day moving average is $544.01 and its 200 day moving average is $510.54.

Synopsys (NASDAQ:SNPS) last released its quarterly earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share for the quarter, missing the consensus estimate of $3.75 by ($1.45). Synopsys had a net margin of 31.04% and a return on equity of 10.82%. The firm had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.77 billion. During the same quarter in the prior year, the firm earned $3.43 earnings per share. The company’s revenue for the quarter was up 14.0% compared to the same quarter last year. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. Research analysts forecast that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Synopsys news, CFO Shelagh Glaser sold 3,655 shares of the business’s stock in a transaction on Friday, September 5th. The stock was sold at an average price of $609.77, for a total value of $2,228,709.35. Following the sale, the chief financial officer directly owned 15,317 shares of the company’s stock, valued at approximately $9,339,847.09. The trade was a 19.27% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Robert G. Painter bought 350 shares of the company’s stock in a transaction on Thursday, September 11th. The stock was bought at an average cost of $425.44 per share, for a total transaction of $148,904.00. Following the completion of the acquisition, the director directly owned 2,291 shares of the company’s stock, valued at approximately $974,683.04. This represents a 18.03% increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders sold 30,894 shares of company stock valued at $16,760,783. 0.62% of the stock is owned by insiders.

Analyst Ratings Changes

Several research firms have recently issued reports on SNPS. Rosenblatt Securities reissued a “neutral” rating and set a $605.00 target price (down from $650.00) on shares of Synopsys in a research note on Wednesday, September 10th. Weiss Ratings reissued a “hold (c)” rating on shares of Synopsys in a research note on Wednesday. Robert W. Baird reissued a “neutral” rating and set a $535.00 target price (down from $670.00) on shares of Synopsys in a research note on Wednesday, September 10th. Zacks Research cut Synopsys from a “hold” rating to a “strong sell” rating in a research note on Friday, September 12th. Finally, The Goldman Sachs Group reduced their target price on Synopsys from $700.00 to $600.00 and set a “buy” rating on the stock in a research note on Wednesday, September 10th. Eleven research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and four have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $575.31.

Synopsys Company Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.